title: Binding units (BU) and the area under binding isotherms (AUI). New indices of effector-target conjugation.
abstract: New methods for simplified quantitation of effector-target conjugation have been developed. The binding unit (BU) is defined as the number of target cells required to bind a specified percentage of effector cells. The number of binding units is determined from binding isotherms in which effector conjugate frequencies are measured by holding constant the number of effector cells and by varying the number of target cells. Alternately, a binding unit can be defined as the number of effector cells required to bind a specified percentage of target cells. In this case, BU is computed from binding isotherms in which target conjugate frequencies are measured at different values of effector cells by holding constant the number of target cells. Also, the area under the curve (AUI) of these isotherms is another index that can be used as an overall measure of the binding capacity in an effector-target system. The experimental values of BU and AUI determined from effector and target isotherms agree well with theoretical predictions based on our previously developed binding model (J. Immunol. Methods (1992) 155, 133-147). The relationship between BU and AUI, and procedures to determine these parameters are shown. The value of these indices to express effector-target conjugation quantitatively has been confirmed by determining the values of BU and AUI for the NK-K562 effector-target system.
authors.affiliation: Laboratory of Physical Chemistry, Faculty of Science, Murcia, Spain.
authors.forename: J
authors.initials: J
authors.lastname: Galvez
authors.forename: L
authors.initials: L
authors.lastname: Cabrera
authors.forename: F
authors.initials: F
authors.lastname: Lajarin
authors.forename: P
authors.initials: P
authors.lastname: Garcia-Peñarrubia
mesh_terms: D000328:Adult; D001665:Binding Sites; D003602:Cytotoxicity, Immunologic; D006801:Humans; D007694:Killer Cells, Natural / Q000276:immunology*; D015464:Leukemia, Myelogenous, Chronic, BCR-ABL Positive / Q000276:immunology* / Q000473:pathology; D016014:Linear Models; D008954:Models, Biological; D014407:Tumor Cells, Cultured